Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1995
05/09/1995US5413774 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
05/09/1995CA2134251A1 N-substituted imidazole derivatives
05/09/1995CA2050293C Acat enzyme inhibitory composition
05/09/1995CA1335504C Substituted 3,4-dihydro-2h-benzopyrans, process for their preparation, their use and pharmaceutical products based on these compounds
05/09/1995CA1335502C Psychotropic bicyclic imides
05/09/1995CA1335501C Methods for preparing sucralfate and aa1-10001
05/07/1995WO1995012601A1 Crystalline penicillin derivative, and its production and use
05/06/1995CA2135131A1 Use of soaps as anti-agers in cosmetic or dermatologic compositions
05/06/1995CA2135000A1 Isoquinolines
05/06/1995CA2134827A1 Methods for lowering serum cholesterol
05/06/1995CA2134826A1 Methods for inhibiting bone loss
05/05/1995CA2135044A1 N-aryl-2-cyano-3-hydroxypropenamides derivatives, proc ess for their preparation, their application as medicaments and pharmaceutical compositions containing them
05/04/1995WO1995011992A1 Antiviral compounds
05/04/1995WO1995011984A2 Recombinant adenoviral vector and methods of use
05/04/1995WO1995011924A1 Non-antigenic branched polymer conjugates
05/04/1995WO1995011914A1 Δ16 unsaturated c¿17? heterocyclic steroids useful as steroid c17-20 lyase inhibitors
05/04/1995WO1995011908A1 Novel phosphorus-containing spin-trap compositions
05/04/1995WO1995011906A1 DIBENZO[b,e]OXEPINE DERIVATIVES, PROCESS FOR PRODUCING THEM AND MEDICAMENTS CONTAINING THEM
05/04/1995WO1995011905A1 2-(pyrazol-3-yl)carbapenem derivatives
05/04/1995WO1995011904A1 Novel a1 adenosine receptor agonists and antiagonists
05/04/1995WO1995011903A1 Tricyclic compounds having affinity for the 5-ht1a receptor
05/04/1995WO1995011900A1 Process for the preparation of substituted thiopyran-1-oxides
05/04/1995WO1995011894A1 Histamine h3-receptor antagonists and therapeutic uses thereof
05/04/1995WO1995011891A1 Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes
05/04/1995WO1995011889A1 Thiazole derivative and drug containing the same
05/04/1995WO1995011887A1 3-aryl-4-alkyl and 4,5-dialkyl-4h-1,2,4-triazoles useful as memory enhancers
05/04/1995WO1995011885A1 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands
05/04/1995WO1995011883A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
05/04/1995WO1995011881A1 Phytosphingosine-based ceramide i analogs
05/04/1995WO1995011878A1 Inhibitors of kynureninase
05/04/1995WO1995011699A1 Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
05/04/1995WO1995011694A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
05/04/1995WO1995011690A1 Desferrioxamine oral delivery system
05/04/1995WO1995011689A1 Use of inhibitors of dipeptidyl-aminopeptidase to block entry of hiv into cells
05/04/1995WO1995011687A1 Therapeutic use of cis-element decoys in vivo
05/04/1995WO1995011684A1 Antagonistic inhibitor against mesenchymal cell growth
05/04/1995WO1995011683A1 Stabilized prostaglandin e¿1?
05/04/1995WO1995011682A2 Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents
05/04/1995WO1995011681A1 Human adenosine receptor antagonists
05/04/1995WO1995011680A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
05/04/1995WO1995011679A1 Use of lobeline for the treatment of nicotine withdrawal
05/04/1995WO1995011678A1 Use of nicotine substitutes for the treatment of nicotine withdrawal
05/04/1995WO1995011677A1 A stable pharmaceutical composition of terfenadine and ibuprofen
05/04/1995WO1995011676A1 Long-acting antifungal o/w preparation
05/04/1995WO1995011675A1 Benzimidazole compounds in the treatment of malaria
05/04/1995WO1995011674A1 Granular preparation
05/04/1995WO1995011673A1 Compounds and methods for treating sickle cell anemia
05/04/1995WO1995011671A1 Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients
05/04/1995WO1995011669A1 Suspension of loteprednol etabonate
05/04/1995WO1995011662A1 Cosmetic composition comprising a hydrocalchone and optionally retinol or a derivative thereof
05/04/1995DE4404990C1 Process for producing a sterile prednisolone gel
05/04/1995CA2175076A1 Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents
05/04/1995CA2175070A1 Dibenzo[b,e]oxepine derivatives, process for producing them and medicaments containing them
05/04/1995CA2175059A1 Granular pharmaceutical preparation
05/04/1995CA2174850A1 Tricyclic compounds having affinity for the 5-ht1a receptor
05/04/1995CA2174747A1 Use of lobeline for the treatment of nicotine withdrawal
05/04/1995CA2173467A1 A stable pharmaceutical composition of terfenadine and ibuprofen
05/04/1995CA2170736A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
05/04/1995CA2152363A1 Novel phosphorus-containing spin-trap compositions
05/04/1995CA2134950A1 Method and compositions for stimulating intracellular glutathione
05/03/1995EP0650966A1 Process for the preparation of a benzo(a)quinolizinone derivative
05/03/1995EP0650964A1 1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives
05/03/1995EP0650961A1 Substituted heterocyclic carboxylic acid amides, their preparation, and their use as medicaments
05/03/1995EP0650960A1 Substituted heterocyclic carboxylic acid amide esters, their preparation and their us as medicaments
05/03/1995EP0650958A1 Hydrazones of indane-triones and their application in therapy
05/03/1995EP0650953A1 Cyclised analogs of metabolites of fatty acids, process for their preparation and pharmaceutical compositions containing them
05/03/1995EP0650732A1 Novel medicinal composition
05/03/1995EP0650730A1 Rapamycin formulations for oral administration
05/03/1995EP0650729A1 Rapamycin formulations for IV injection
05/03/1995EP0650728A1 Pharmaceutical compositions containing piperine and an antituberculosis or antileprosydrug
05/03/1995EP0650727A1 Use of hydroxychloroquine for treatment of graft-versus-host disease
05/03/1995EP0650726A1 4-Piperidino-piperidine for the treatment of tumor
05/03/1995EP0650725A1 Compositions containing salts of L-2-oxothiazolidine-4-carboxylic acid and their use for stimulating intracellular glutathione
05/03/1995EP0650724A1 Methods for inhibiting uterine fibrosis
05/03/1995EP0650723A2 Novel pharmaceutical use of forskolin derivatives
05/03/1995EP0650720A1 Skin care and deodorant compositions
05/03/1995EP0650496A1 Anti-inflammatory compounds for ophthalmic use
05/03/1995EP0650495A1 Improved antiandrogens
05/03/1995EP0650493A1 Hybrid oligonucleotide phosphorothioates
05/03/1995EP0650492A1 Reducing inflammation by time dependent administration of oligosaccharides glycosides related to blood group determinants
05/03/1995EP0650489A1 Rapamycin derivatives
05/03/1995EP0650488A1 Quinoline and naphthyridine prodrugs
05/03/1995EP0650487A1 Novel diazabicycloalkenes and processes for the preparation thereof
05/03/1995EP0650486A1 New analgesic and nootropic drugs
05/03/1995EP0650485A1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
05/03/1995EP0650484A1 Endothelin receptor antagonists
05/03/1995EP0650483A1 (3R,4R)-$g(D)?6 -TETRAHYDROCANNABINOL-7-OIC ACIDS
05/03/1995EP0650482A1 Pesticidal pyrimidine compounds
05/03/1995EP0650481A1 Pyrimidine compounds used in the therapy
05/03/1995EP0650480A1 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines
05/03/1995EP0650475A1 4-amino-n --(4-methyl-4-piperidinyl)-2-methoxybenzamides
05/03/1995EP0650474A1 Novel piperidyl amides, sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis
05/03/1995EP0650378A1 Treatment of physiological conditions with degassed perfluorocarbon liquid
05/03/1995EP0650377A1 Implanting devices for release of neuroinhibitory compounds
05/03/1995EP0650374A1 Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant
05/03/1995EP0650373A1 Sustained release alginate fibre and process for the preparation thereof.
05/03/1995EP0650372A1 Compounds for cancer imaging and therapy
05/03/1995EP0650368A1 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity
05/03/1995EP0650366A1 Compositions and methods for treating wounds
05/03/1995EP0650365A1 Biocidal composition containing mustard seed plant extract.
1 ... 7021 7022 7023 7024 7025 7026 7027 7028 7029 7030 7031 7032 7033 7034 7035 7036 7037 7038 7039 7040 7041 ... 7860